Rupture of liver metastasis in high-volume metastatic prostate cancer patient on androgen deprivation therapy combined with upfront docetaxel chemotherapy.

The addition of upfront docetaxel to androgen deprivation therapy may be effective in patients with high-volume metastatic hormone-sensitive prostate cancer; however, strict observation is required to monitor for the occurrence of rare complications, including hepatorrhexis.